A randomized clinical trial of dentin hypersensitivity reduction over one month after a single topical application of comparable materials

Sci Rep. 2021 Mar 24;11(1):6793. doi: 10.1038/s41598-021-86258-3.

Abstract

Dentinal hypersensitivity (DH) is a condition that causes patient discomfort. To evaluate the clinical efficacy of Gluma, fluoride varnish and Tetric N-Bond self-etch system in relieving DH immediately and over 30 days following a single topical application. The present randomized clinical trial was conducted on 55 patients with an age range 20-49 years. 70 teeth in total were incorporated and randomly assigned to the three groups. Parameters examined were: Tactile, air blast, and cold stimuli. VAS was used to assess tactile stimulus whereas the Schiff Cold Scale for air blast and cold stimuli. DH was evaluated immediately, at two weeks and 1 month follow up. Gluma showed a statistically significant reduction in DH scores over other materials. It was concluded that Gluma have statistically significant results over other materials in relieving DH immediately and over 30 days following a single topical application.Trial Registration: Clinical Trials.gov Identifier: NCT04351412, King Abdulaziz University Protocol Record 129-09-19. Registered 17 April 2020 - Retrospectively registered. http://ClinicalTrials.gov/NCT04351412 .

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Adult
  • Cold Temperature
  • Composite Resins / therapeutic use
  • Dentin Desensitizing Agents / therapeutic use*
  • Dentin Sensitivity / drug therapy*
  • Dentin Sensitivity / pathology
  • Double-Blind Method
  • Drug Administration Schedule
  • Follow-Up Studies
  • Glutaral / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Polymethacrylic Acids / therapeutic use
  • Sodium Fluoride / therapeutic use
  • Treatment Outcome
  • Young Adult

Substances

  • Composite Resins
  • Dentin Desensitizing Agents
  • Polymethacrylic Acids
  • Tetric
  • Sodium Fluoride
  • Gluma
  • Glutaral

Associated data

  • ClinicalTrials.gov/NCT04351412